The USS Nautilus was the world's first nuclear-powered submarine. It participated in scientific and military operations ...

Seattle's Nautilus Biotechnology is laying off 16% of workforce, and plans to release its commercial platform in late 2026.

Does Lincoln nail American luxury with the Nautilus? We take a deep dive inside this excellent new Lincoln SUV in this ...

The 2025 Aviator has a new 12.4-inch digital instrumentation panel and a 13.2-inch touchscreen infotainment system. Featuring ...

Nautilus Biotechnology CEO Sujal Patel had to deliver tough news on a Thursday morning call with analysts. The company has ...

Nautilus Solar Energy® LLC, a leading provider of community solar in the U.S. and a contributor to America’s energy independence transition, today announced its 2024 energy impact metrics. In another ...

Despite a delay in the platform launch, Nautilus Biotechnology Inc (NAUT) showcases advancements in proteomics and maintains a strong cash position.

Guggenheim lowered the firm’s price target on Nautilus Biotechnology (NAUT) to $2.50 from $4 and keeps a Buy rating on the shares. A key area ...

SEATTLE, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial ...

Cash, cash equivalents, and investments were $206.3M as of December 31, 2024. “2024 was a year of innovation and meaningful accomplishment for ...